Drug Tracking System

Abstract

To provide a medical supply tracking management system.SOLUTION: A medical supply tracking management system includes a database, an information transmission and reception module, and a management module. The information transmission and reception module is used for receiving tag information of a medical supply, a manufacturing process, a logistics process, and a use process of the medical supply, and for sending the manufacturing process, the logistics process, and the use process to a block chain network and the database. A signal of the management module is connected to the information transmission and reception module, and the management module includes a history query module for acquiring the manufacturing process, the logistics process, and the use process of the medical supply corresponding to an identification label from the database on the basis of the tag information.SELECTED DRAWING: Figure 1

Description

[Technical field]

[0001] The present invention relates to a medical supply tracking management system, and more particularly, to a medical supply tracking management system that allows users to check medical information via a blockchain network. [Background technology]

[0002] In the process of treating diseases and administering vaccines, various medicines need to be used. After pharmaceutical companies manufacture the medicines, they are transported to hospitals by logistics organizations and then administered to patients by medical staff at the hospitals. Summary of the Invention [Problem to be solved by the invention]

[0003] However, there is currently no system that can trace the manufacturer, transportation logistics, and use process of pharmaceuticals (the history of use from the manufacturing end to the medical staff), and there is a need to provide a pharmaceutical tracking and management system. It is necessary to enable users of the manufacturing end, logistics end, and user end of pharmaceuticals to trace the manufacturer, transportation logistics, and use process of pharmaceuticals, monitor and manage errors in the manufacturing end, transportation logistics, and use process to prevent the ingredients of drugs and vaccines from deteriorating, and clarify which of the manufacturer, logistics carrier, or hospital injection storage is responsible when a patient experiences an allergic or other side effect. It is also necessary to provide fully traceable overall transportation information, injection information, and patient information to solve the problems existing in the prior art.

[0004] Therefore, the present inventors believed that the above-mentioned drawbacks could be improved, and as a result of extensive research, they came to propose the present invention, which effectively improves the above-mentioned problems through rational design.

[0005] The present invention has been made in consideration of such conventional problems. In order to solve the above problems, the present invention aims to provide a pharmaceutical tracking management system that allows users to check medical information via a blockchain network. [Means for solving the problem]

[0006] In order to achieve the above object, the drug tracking management system of the present invention is used to receive drug manufacturing processes, logistics processes, and use processes transmitted by multiple third-party mechanisms, and for users to track the manufacturing processes, logistics processes, and use processes. The drug has an identification label including tag information, and the drug tracking management system includes a database, an information transmission and reception module, and a management module. The information transmission and reception module receives the tag information, the manufacturing process, the logistics process, and the use process of the drug, and transmits the manufacturing process, the logistics process, and the use process to a blockchain network and a database. The management module is signal-connected to the information transmission and reception module, and includes a history query module for obtaining the manufacturing process, the logistics process, and the use process of the drug corresponding to the identification label from the database based on the tag information.

[0007] According to one aspect of the present invention, the plurality of third party mechanisms includes pharmaceutical manufacturers, distributors, and medical institutions.

[0008] According to one aspect of the present invention, the information transmitting and receiving module receives the manufacturing process, the logistics process, and the usage process transmitted by the manufacturer, the logistics company, and the user end, respectively.

[0009] According to one aspect of the present invention, the user end is equipped with a tag reader, and the user obtains tag information through the tag reader.

[0010] According to one embodiment of the present invention, the identification label is an RFID label or an NFC label, and the tag reader is an RFID (Radio Frequency Identification; RFID) reader or an NFC tag reader.

[0011] According to one aspect of the invention, the pharmaceutical product comprises an injectable drug.

[0012] According to one aspect of the present invention, the use process is the hospital's patient's injection end information.

[0013] Other features of the present invention will become apparent from the following detailed description of the present invention and the accompanying drawings. [Brief description of the drawings]

[0014] [Figure 1] A system configuration diagram showing a drug tracking management system, a blockchain network, an external computer, a pharmaceutical factory computer, a logistics computer, and a medical computer in one embodiment of the present invention. [Diagram 2] FIG. 2 is an exploded view of a pharmaceutical product according to one embodiment of the present invention. [Diagram 3] FIG. 1 is a schematic diagram showing a pharmaceutical product and a syringe according to one embodiment of the present invention. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0015] Hereinafter, an embodiment of the present invention will be described in detail with reference to the drawings. Note that the present invention is not limited to the following examples, and can be modified as desired without departing from the gist of the present invention.

[0016] First, a specific embodiment of the present invention will be described with reference to Figures 1 to 3. Figure 1 is a system configuration diagram showing a drug tracking management system, a block chain network, an external computer, a pharmaceutical factory computer, a logistics computer, and a medical computer according to an embodiment of the present invention. Figure 2 is an exploded view of a drug according to an embodiment of the present invention. Figure 3 is a schematic diagram showing a drug and a syringe according to an embodiment of the present invention.

[0017] In one embodiment of the present invention, referring to FIG. 1, the drug tracking management system 900 is used by any one user of a plurality of third party organizations to track the manufacturing process 211, the logistics process 212, and the use process 213 of the drug 1. The third party organizations include a manufacturer, a logistics company, and a user end. The manufacturer is a pharmaceutical factory organization that manufactures the drug 1, and the pharmaceutical factory organization has a pharmaceutical factory computer 600 including a pharmaceutical factory computer blockchain module 610 whose signal is connected to the blockchain network 300. The logistics company is a logistics organization that transports the drug 1 from the pharmaceutical factory organization to a hospital or pharmacy that needs the drug 1. The logistics organization has a logistics computer 700 including a logistics computer blockchain module 710 whose signal is connected to the blockchain network 300. The user end may be a medical end such as a medical institution, i.e., a hospital or pharmacy that receives the drug 1. Medical Institutions has a medical computer 800 equipped with a medical computer blockchain module 810 and a tag reader 400. The medical computer blockchain module 810 is used to connect signals to the blockchain network 300. However, the user end is not limited to the above, and may be a treatment end (e.g., a patient) such as a patient who uses a medicine 1, a payment end (e.g., an insurance company), or a third-party certification authority end (e.g., a support organization).

[0018] In one embodiment of the present invention, referring to Fig. 2 and Fig. 3, the medicine 1 is used to contain a medicinal liquid or a vaccine to be taken by a patient or injected into the patient's body by a syringe 200. The medicine 1 includes a bottle body 10, a chip set 20, a cover 30, a sealing strip 40, and a battery 50. The bottle body 10 is used to contain a medicinal liquid or a vaccine. The cover 30 is fitted to the opening of the bottle body 10, and the sealing strip 40 is used to seal the bottle body 10 by the cover 30 and to allow a user to check whether the cover 30 has been opened. The battery 50 is installed in the bottle body 10 and supplies power to the chip set 20.

[0019] In one embodiment of the present invention, as shown in FIG. 1 and FIG. 2, the chipset 20 is a flexible chip and is installed in the bottle body 10. The chipset 20 includes an identification label 21, a medical product blockchain module 22, a positioning module 23, an anti-counterfeiting module 24, and a temperature control module 25. The identification label 21 is an RFID label (Radio Frequency Identification; RFID) or an NFC label. The identification label 21 includes tag information for storing the manufacturing process 211, the logistics process 212, and the use process 213 of the drug 1. The manufacturing process 211 is provided by the pharmaceutical factory computer 600, and the manufacturing process 211 includes the production and manufacturing information of the drug 1, such as the National Drug Code (NDC), serial number, patch number, expiration date, ingredients, and product transaction details recorded in the supply chain. The logistics process 212 is provided by the logistics computer 700. The logistics process 212 includes information such as temperature control records of the entire transport process of the medicine 1, positioning records of the entire process, transport vehicle number information, transport personnel information, etc. The usage process 213 is provided by the medical computer 800. The usage process 213 includes injection end information of the hospital's patient, such as the name of the medical institution that uses the medicine 1 or the pharmacy that sells the medicine 1, the doctor who injects the medicine 1, the time when the medicine 1 is administered, information of the patient who injects the medicine 1, the date of birth of the patient who injects the medicine 1, vital signs of the patient who injects the medicine 1 at the time of injection (e.g., blood pressure, heart rate, respiration, body temperature, weight), past allergic reactions of the patient who injects the medicine 1, past injection records of the patient who injects the medicine 1, the medical history of the family of the patient who injects the medicine 1, the current medical history and gene sequence of the patient who injects the medicine 1, and information to be provided to medical personnel at the medical service end.

[0020] The medical supplies blockchain module 22 is equipped with a computing chip and a wireless communication chip or communication antenna whose signal is connected to the blockchain network 300. As a result, the manufacturing process 211, logistics process 212, and use process 213 of the medicine 1 are recorded in the blockchain network 300, and the manufacturing process 211, logistics process 212, and use process 213 of the medicine 1 are recorded and traceable due to the characteristics that the blockchain network 300 can be traced back and the records are difficult to tamper with. The positioning module 23 is a Global Positioning System chip, and the positioning module 23 positions the medicine 1, determines the current position of the medicine 1, records the relationship between the transportation process and the time point throughout the entire process, confirms the point of transportation time, and records the transportation route. In this embodiment, the anti-counterfeiting module 24 is an anti-counterfeiting label for users to confirm the reliability and safety of the medicine 1. The temperature control module 25 is a chip with a temperature sensing function, and the temperature control module 25 measures and manages the temperature of the medicine 1. This ensures that Drug 1 is at the right temperature and that a hot environment does not affect the pharmacological activity of Drug 1.

[0021] In addition to connecting to the blockchain network 300 to record information through the medical supplies blockchain module 22, the pharmaceutical factory computer blockchain module 610 of the pharmaceutical factory computer 600 connects to the blockchain network 300 to record the production process 211. The logistics computer blockchain module 710 of the logistics computer 700 connects to the blockchain network 300 to record the logistics process 212. The medical computer blockchain module 810 of the medical computer 800 connects to the blockchain network 300 to record the usage process 213.

[0022] In one embodiment of the present invention, as shown in FIG. 1, the drug tracking management system 900 includes a server 100. The server 100 of the drug tracking management system 900 is connected to a blockchain network 300, an external computer 500, a pharmaceutical factory computer 600, a logistics computer 700, and a medical computer 800. The server 100 includes a blockchain module 110, an information transmission and reception module 120, a management module 130, and a database 140. The blockchain module 110 includes a computing chip and a wireless communication chip or communication antenna for connecting a signal to the blockchain network 300 and obtaining the manufacturing process 211, logistics process 212, and use process 213 of the drug 1 recorded in the blockchain network 300. The information transmission and reception module 120 is, for example, a network card, and is used to connect to the external computer 500, the pharmaceutical factory computer 600, the logistics computer 700, and the medical computer 800 to transmit information between them, and to receive the tag information, manufacturing process, logistics process, and use process of the drug 1. That is, the information transmission and reception module 120 receives the manufacturing process 211, logistics process 212, and use process 213 of the drug 1 transmitted by the manufacturer, logistics company, and user end, respectively, and transmits the received manufacturing process, logistics process, and use process to the block chain network 300 and the database 140. The management module 130 is a central processing unit whose signals are connected to the block chain module 110 and the information transmission and reception module 120. The management module 130 includes a history query module 131 that obtains the manufacturing process, logistics process, and use process of the drug 1 corresponding to the identification label from the database 140 based on the tag information, and transmits the manufacturing process, logistics process, and use process to the information transmission and reception module 120. The information transmission and reception module 120 transmits the manufacturing process, logistics process, and use process to the external computer 500, the pharmaceutical factory computer 600, the logistics computer 700, and the medical computer 800.The database 140 is signal-connected to the blockchain module 110, the information transmission and reception module 120, and the management module 130, and the database 140 is used to store identification labels, manufacturing processes, logistics processes, and usage processes.

[0023] In one embodiment of the present invention, the tag reader 400 is an RFID (Radio Frequency Identification; RFID) reader or an NFC tag reader. The tag reader 400 is connected to the server 100 by a signal and is used to read at least one of the manufacturing process 211, the logistics process 212, and the use process 213 in the identification label 21. Alternatively, the tag reader 400 inputs the manufacturing process 211, the logistics process 212, and the use process 213 into the identification label 21, and the manufacturing process 211, the logistics process 212, and the use process 213 are recorded in the blockchain network 300 by the medical supplies blockchain module 22. Alternatively, the tag reader 400 is used to obtain the manufacturing process 211, the logistics process 212, and the use process 213 recorded in the blockchain network 300 by the medical supplies blockchain module 22 and input them into the identification label 21. According to a specific embodiment of the present invention, the tag reader 400 is directly installed in the pharmaceutical company that manufactures the drug 1, the logistics organization that transports the drug 1, or the medical organization that uses or sells the drug 1, and the supply chain platform management server provided by trace-link (registered trademark), and serves as information for tracking the drug supply chain on a global scale. The user scans the identification label 21 with the tag reader 400 to obtain tag information, and medical personnel can learn the manufacturing, distribution, and use process of the drug 1 to ensure the safety of patients who take the drug.

[0024] When the pharmaceutical factory organization produces the drug 1, the workers of the pharmaceutical factory organization fill the bottle body 10 with a medicinal liquid or vaccine, cover the bottle body 10 with a cover 30, cover the bottle body 10 with a sealing strip 40, and seal the bottle body 10 with the cover 30. Then, the workers of the pharmaceutical factory organization operate the pharmaceutical factory computer 600 to connect a signal to the tag reader 400, input the manufacturing process 211 of the drug 1 into the identification label 21, record the manufacturing process 211 in the blockchain network 300 through the medical supplies blockchain module 22, and transmit the manufacturing process 211 to the drug tracking management system 900 through the network. After the production of the drug 1 is completed, the worker of the logistics organization transports the drug 1 from the pharmaceutical factory organization to the medical organization. During the process of the worker of the logistics organization transporting the drug 1, the worker of the logistics organization operates the logistics computer 700 to connect a signal to the tag reader 400, inputs the logistics process 212 of the drug 1 into the identification label 21, records the logistics process 212 in the blockchain network 300 through the medical supply blockchain module 22, and transmits the logistics process 212 to the drug tracking management system 900 through the network. After the drug 1 is transported to the medical organization, the worker of the medical organization operates the medical computer 800 to connect a signal to the tag reader 400, inputs the use process 213 of the drug 1 into the identification label 21, records the use process 213 in the blockchain network 300 through the medical supply blockchain module 22, and transmits the use process 213 to the drug tracking management system 900 through the network. Thus, the block chain network 300 and the identification label 21 together completely record the manufacturing process 211, logistics process 212, and usage process 213 of the drug 1. In addition, after the information transmission and reception module 120 of the drug tracing management system 900 receives the manufacturing process 211, logistics process 212, and usage process 213, it transmits the manufacturing process 211, logistics process 212, and usage process 213 to the database 140, so that the drug tracing management system 900 completely records the manufacturing process 211, logistics process 212, and usage process 213 of the drug 1.

[0025] If a patient who uses the drug 1 experiences an allergic reaction or other side effect, a medical institution worker or the patient can operate the external computer 500 to connect to the drug tracking management system 900, read the tag information on the identification label 21 of the drug 1 using the tag reader 400, and transmit the tag information to the drug tracking management system 900 to find out whether any errors have occurred in the production, distribution, and use process of the drug 1. When the information transmitting and receiving module 120 receives the tag information from the external computer 500, the history query module 131 of the management module 130 obtains the production process, logistics process, and use process of the drug 1 corresponding to the identification label from the database 140 based on the content of the tag information. The information transmission / reception module 120 transmits the manufacturing process, logistics process, and usage process to the external computer 500, so that the workers and patients operating the external computer 500 can check the returned manufacturing process 211, logistics process 212, and usage process 213 to learn the manufacturing process 211, logistics process 212, and usage process 213 of the drug 1, understand which of the pharmaceutical factory organization, the logistics organization, or the medical organization is responsible, and clarify the responsibility for medical disputes and relief for drug side effects.

[0026] However, the manner in which the workers of each unit obtain the manufacturing process 211, the logistics process 212, and the use process 213 is not limited to the above, for example, the workers of each unit may operate the pharmaceutical factory computer 600, the logistics computer 700, or the medical computer 800 to connect to the drug tracking management system 900 and obtain response information. Alternatively, the workers may use the tag reader 400 to read the manufacturing process 211, the logistics process 212, and the use process 213 stored in the identification label 21.

[0027] The drug tracking management system 900 of the present invention manages and tracks the manufacturing process, storage and transportation process, and use process of drugs, improving the safety of drug use for patients and medical institutions. The drug 1 and drug tracking management system 900 of the present invention meet the minimum sales package indicated on prescription drugs, improve the efficiency of the supply chain, eliminate illegal counterfeit drugs, improve prescription drug recall procedures and efficiency, and clarify the responsibility for medical disputes and drug side effect damage relief. In addition, the drug tracking management system 900 of the present invention collects medical history information of patients who use the drug 1 of the present invention for injection from all over the world, and creates a big data database of drugs and vaccine injections, compares the association between vaccines / drugs and gene sequences, uploads the database to the blockchain network, and stores and analyzes it by pharmaceutical factory organizations (manufacturing end), logistics organizations (logistics end), medical organizations (doctor end), and third-party certification authority remote backup data end, and helps patients inject injections and personally store electronic medical records, and is compatible with the electronic medical records of the blockchain.

[0028] The above description is for the purpose of explaining the present invention, and should not be interpreted as limiting the invention described in the claims or restricting the scope of the invention. Furthermore, the configuration of each part of the present invention is not limited to the above embodiment, and various modifications are possible within the technical scope described in the claims. [Explanation of symbols]

[0029] 1. Pharmaceuticals 10 Bottle body 20 Chipset 21 Identification Label 211 Manufacturing Process 212 Logistics Process 213 Use Process 22 Medical Supplies Blockchain Module 23 Positioning module 24 Anti-counterfeiting module 25 Temperature Control Module 30 Cover 40 Seal Strip 50 Battery 100 servers 110 Blockchain Module 120 Information transmission and reception module 130 Management Module 140 Databases 200 syringe 300 Blockchain Networks 400 Tag Reader 500 External Computers 600 Pharmaceutical Factory Computer 610 Pharmaceutical Factory Computer Blockchain Module 700 Logistics Computer 710 Logistics Computer Blockchain Module 800 Medical Computers 810 Medical Computer Blockchain Module 900 Drug Tracking Management System

Claims

1. A pharmaceutical tracking and management system for receiving pharmaceutical manufacturing processes, distribution processes, and use processes transmitted from a plurality of third party organizations, and used by a user to track the manufacturing processes, distribution processes, and use processes, wherein the pharmaceutical products are provided with identification labels including tag information, A database; an information transceiver module for receiving the tag information, the manufacturing process, the logistics process, and the use process of the pharmaceutical product and transmitting the manufacturing process, the logistics process, and the use process to a blockchain network and the database; A management module connected to the information transmission and reception module includes a history query module for obtaining the manufacturing process, the logistics process, and the use process of the drug corresponding to the identification label from the database based on the tag information, and the tag information is used to store the manufacturing process, the logistics process, and the use process, and the manufacturing process is stored in the National Drug Code (NDC) of the drug. and a management module in which the information on the drug usage includes information on the medical institution that uses the drug, the name of the pharmacy that sells the drug, the doctor that injects the drug, the time at which the drug is administered, information on the patient that injects the drug, the date of birth of the patient that injects the drug, vital signs of the patient at the time of injection, past allergic reactions of the patient that injects the drug, past injection records of the patient that injects the drug, medical history of the family of the patient that injects the drug, current medical history of the patient that injects the drug, and gene sequence of the patient that injects the drug, and the vital signs include blood pressure, heart rate, respiration, body temperature, and body weight.

2. The pharmaceutical tracking system according to claim 1 , wherein the plurality of third-party organizations include a manufacturer of the pharmaceutical, a logistics company, and a medical institution.

3. The pharmaceutical tracking management system according to claim 2, characterized in that the information transmission and reception module receives the manufacturing process transmitted by the manufacturer, the logistics process transmitted by the logistics company, and the usage process transmitted by the medical institution, respectively.

4. The pharmaceutical tracking management system described in Claim 3, characterized in that the medical institution is equipped with a tag reader, and the user obtains the tag information by means of the tag reader.

5. The medicine tracking and management system according to claim 4, wherein the identification label is an RFID label or an NFC label, and the tag reader is an RFID (Radio Frequency Identification: RFID) reader or an NFC tag reader.

6. The drug tracking and management system of claim 5 , wherein the drug includes an injection drug.

Images